Top Page
Haleon PLC Sponsored ADR
(NYSE:HLN)
Haleon PLC Sponsored ADR (HLN) vs. SPDR S&P 500 ETF (SPY)
Haleon PLC Sponsored ADR Business Overview & Revenue Model
Haleon PLC Sponsored ADR Key Performance Indicators (KPIs)
Shows how revenue is distributed across different business units, highlighting which areas are driving growth and which may need strategic adjustments.
Main Street DataHaleon PLC Sponsored ADR Earnings Call Summary
Haleon PLC Sponsored ADR Financial Statement Overview
| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 11.23B | 11.30B | 10.86B | 9.54B | 9.89B |
| Gross Profit | 6.95B | 6.96B | 6.58B | 5.95B | 5.91B |
| EBITDA | 2.51B | 2.35B | 2.18B | 2.21B | 1.91B |
| Net Income | 1.44B | 1.05B | 1.06B | 1.39B | 1.15B |
Balance Sheet | |||||
| Total Assets | 34.31B | 34.05B | 34.81B | 34.45B | 34.13B |
| Cash, Cash Equivalents and Short-Term Investments | 2.25B | 1.04B | 684.00M | 414.00M | 334.00M |
| Total Debt | 10.10B | 9.46B | 10.44B | 991.00M | 487.00M |
| Total Liabilities | 18.09B | 17.33B | 18.36B | 7.97B | 7.91B |
| Stockholders Equity | 16.17B | 16.61B | 16.33B | 26.36B | 26.11B |
Cash Flow | |||||
| Free Cash Flow | 2.05B | 1.76B | 1.74B | 1.06B | 1.09B |
| Operating Cash Flow | 2.30B | 2.10B | 2.06B | 1.36B | 1.41B |
| Investing Cash Flow | 528.00M | -134.00M | -8.78B | -33.00M | 1.03B |
| Financing Cash Flow | -1.54B | -1.57B | 6.91B | -1.24B | -2.44B |
Haleon PLC Sponsored ADR Technical Analysis
Haleon PLC Sponsored ADR Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | 12.44B | 18.42 | 16.96% | 0.62% | 13.13% | -0.47% | |
71 Outperform | 47.75B | 49.67 | 1.99% | 3.99% | 1.36% | -1.81% | |
69 Neutral | $43.43B | 22.26 | 9.20% | 1.81% | 0.58% | 45.74% | |
58 Neutral | 21.52B | -127.11 | -30.46% | ― | 2.43% | 64.37% | |
51 Neutral | 2.91B | -37.82 | -1.80% | 5.42% | -2.32% | 35.46% | |
49 Neutral | 11.22B | -3.31 | -3.40% | 4.99% | -7.47% | -438.39% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
Haleon PLC Sponsored ADR Corporate Events
On September 12, 2025, Haleon PLC announced the purchase and cancellation of 273,737 ordinary shares as part of the second tranche of its share buyback program initiated on July 31, 2025. This transaction is expected to impact the company’s share capital and voting rights, with the current number of ordinary shares with voting rights standing at 8,950,849,678. This strategic move is likely to influence Haleon’s market positioning and shareholder interests, aligning with the company’s ongoing financial strategies.
On September 11, 2025, Haleon PLC announced the purchase of 172,878 ordinary shares for cancellation as part of the second tranche of its share buyback program initiated on July 31, 2025. This transaction reflects Haleon’s strategic efforts to manage its capital structure and potentially enhance shareholder value, impacting the company’s share capital and voting rights.
On September 10, 2025, Haleon PLC announced a notification and public disclosure regarding transactions by Persons Discharging Managerial Responsibilities (PDMRs) under the UK Market Abuse Regulation. The transactions involved the acquisition of Partnership Shares and the award of Matching Shares under the company’s Share Reward Plan by Adrian Morris, General Counsel, and Tamara Rogers, Chief Marketing Officer, on September 9, 2025, at the London Stock Exchange. This disclosure highlights Haleon’s commitment to transparency and regulatory compliance, potentially impacting stakeholder confidence and market perception.
On September 10, 2025, Haleon PLC announced the purchase of 1,590,000 ordinary shares for cancellation as part of the second tranche of its share buyback program initiated on July 31, 2025. This transaction, conducted on September 9, 2025, aims to optimize the company’s capital structure and potentially enhance shareholder value by reducing the number of shares with voting rights to 8,951,243,846. This strategic move may strengthen Haleon’s market position and reflect positively on its commitment to returning value to its shareholders.
On September 9, 2025, Haleon PLC announced the purchase of 1,200,000 ordinary shares for cancellation as part of the second tranche of its share buyback program initiated on July 31, 2025. This move is likely to impact the company’s share capital and voting rights, with the current number of ordinary shares with voting rights standing at 8,952,833,846. The buyback reflects Haleon’s strategic efforts to manage its capital structure and could influence shareholder value positively.
On September 5, 2025, Haleon PLC announced a notification regarding the grant of share awards to its Persons Discharging Managerial Responsibilities (PDMRs) under the Haleon Share Value Plan and Performance Share Plan. These awards, which are subject to continued employment and performance conditions, reflect the company’s adherence to its Directors’ Remuneration Policy and include malus and clawback provisions. This announcement highlights Haleon’s commitment to aligning managerial incentives with company performance, potentially impacting its market positioning and stakeholder trust.
On September 5, 2025, Haleon PLC announced the purchase and cancellation of 353,360 ordinary shares as part of the second tranche of its share buyback program initiated on July 31, 2025. This move is part of Haleon’s strategic financial management to optimize its capital structure, potentially enhancing shareholder value and affirming its strong market position in the consumer health industry.
On September 4, 2025, Haleon PLC announced the purchase and cancellation of 354,000 ordinary shares as part of the second tranche of its share buyback program initiated on July 31, 2025. This transaction, conducted on September 3, 2025, reflects Haleon’s strategic move to manage its share capital and potentially enhance shareholder value, impacting the company’s market positioning and stakeholder interests.
On September 2, 2025, Haleon PLC executed a transaction involving the purchase and cancellation of 2,900,000 ordinary shares as part of the second tranche of its share buyback program announced in July 2025. This move is likely to impact the company’s share capital structure, reducing the number of shares with voting rights to 8,952,441,206, which may influence shareholder notifications under FCA’s Disclosure Guidance and Transparency Rules.
On September 1, 2025, Haleon PLC reported that as of August 31, 2025, the total number of shares issued was 8,959,221,411, with 3,880,205 held as treasury shares. Consequently, the number of ordinary shares with voting rights stands at 8,955,341,206. This figure is crucial for shareholders and others with notification obligations to determine their interest in the company under the FCA’s Disclosure Guidance and Transparency Rules.
On September 1, 2025, Haleon PLC announced the purchase of 2,062,463 ordinary shares for cancellation as part of the second tranche of its share buyback program initiated on July 31, 2025. This transaction, completed on August 29, 2025, is part of Haleon’s strategic efforts to manage its capital structure and enhance shareholder value, potentially impacting its market positioning and investor relations.
On August 29, 2025, Haleon plc announced the purchase and cancellation of 2,191,437 ordinary shares as part of the second tranche of its share buyback program initiated on July 31, 2025. This transaction, conducted on August 28, 2025, aims to optimize the company’s capital structure and potentially enhance shareholder value. Following this transaction, Haleon’s registered share capital stands at 8,961,283,874 ordinary shares, with 3,880,205 held as treasury shares, leaving 8,957,403,669 shares with voting rights. This strategic move reflects Haleon’s commitment to maintaining a robust financial position and could influence its market standing and investor relations.
On August 28, 2025, Haleon PLC announced the completion of a significant transaction involving the purchase and cancellation of 2,875,831 ordinary shares as part of the second tranche of its share buyback program initiated on July 31, 2025. This move is expected to impact the company’s share capital and voting rights, with the registered share capital now standing at 8,963,475,311 ordinary shares, of which 3,880,205 are held as treasury shares. The transaction reflects Haleon’s strategic efforts to manage its capital structure and enhance shareholder value.
On August 27, 2025, Haleon PLC announced the purchase and cancellation of 2,975,063 ordinary shares as part of its ongoing share buyback program, initially announced on July 31, 2025. This transaction, completed on August 26, 2025, is part of Haleon’s strategy to optimize its capital structure and enhance shareholder value, potentially impacting its market position and stakeholder interests.
On August 26, 2025, Haleon PLC announced the purchase and cancellation of 1,369,903 ordinary shares as part of the second tranche of its share buyback program initiated on July 31, 2025. This transaction, completed on August 22, 2025, reflects the company’s strategic move to manage its share capital and potentially enhance shareholder value, impacting the number of shares with voting rights and aligning with market regulations.
On August 22, 2025, Haleon PLC announced the purchase and cancellation of 175,642 ordinary shares as part of its share buyback program initiated on July 31, 2025. This transaction, executed on August 21, 2025, reflects Haleon’s strategic financial management to optimize its capital structure and enhance shareholder value. Following this buyback, the company’s registered share capital stands at 8,970,696,108 ordinary shares, with 8,966,815,903 shares holding voting rights. This move may influence stakeholder decisions, particularly regarding interest notifications under the FCA’s Disclosure Guidance and Transparency Rules.
On August 21, 2025, Haleon PLC announced the purchase and cancellation of 930,345 ordinary shares as part of the second tranche of its share buyback program initiated on July 31, 2025. This transaction, executed on August 20, 2025, is part of Haleon’s strategy to manage its share capital and potentially enhance shareholder value. Following this transaction, the company’s registered share capital stands at 8,970,871,750 ordinary shares, with 3,880,205 held as treasury shares, affecting the number of shares with voting rights and shareholder notifications under FCA regulations.
On August 20, 2025, Haleon PLC announced a TR-1 notification regarding major holdings in the company. Wellington Management Group LLP, based in Boston, USA, has acquired or disposed of voting rights, resulting in a 5.01% total voting rights in Haleon. This change in holdings reflects a slight increase from previous notifications and may impact Haleon’s market positioning and stakeholder interests.
On August 15, 2025, Haleon PLC announced the purchase and cancellation of 1,399,293 ordinary shares as part of the second tranche of its share buyback program initiated on July 31, 2025. This transaction reflects the company’s strategic move to optimize its capital structure and potentially enhance shareholder value by reducing the number of shares with voting rights to 8,971,026,290, which may impact shareholder interests under the FCA’s Disclosure Guidance and Transparency Rules.
On August 14, 2025, Haleon PLC announced the purchase of 830,000 ordinary shares for cancellation as part of the second tranche of its share buyback program initiated on July 31, 2025. This transaction is expected to impact the company’s share capital and voting rights, with the total number of ordinary shares now at 8,972,425,583. This strategic move is likely to influence the company’s market positioning and shareholder interests.
On August 13, 2025, Haleon PLC announced the purchase and cancellation of 1,400,000 ordinary shares as part of the second tranche of its share buyback program, initially announced on July 31, 2025. This move is part of Haleon’s strategic efforts to optimize its capital structure and enhance shareholder value, reflecting positively on its market positioning and potentially impacting shareholder interests.
On August 12, 2025, Haleon PLC announced a notification and public disclosure concerning transactions by Persons Discharging Managerial Responsibilities (PDMRs) under the UK Market Abuse Regulation. The transactions, which took place on August 11, 2025, involved the acquisition of Partnership Shares and the award of Matching Shares under the company’s Share Reward Plan by Adrian Morris, General Counsel, and Tamara Rogers, Chief Marketing Officer. This announcement reflects Haleon’s commitment to transparency in its managerial operations and could potentially impact stakeholder confidence in the company’s governance practices.
On August 12, 2025, Haleon PLC announced the purchase of 1,200,000 ordinary shares for cancellation as part of its share buyback program initiated on July 31, 2025. This transaction, which took place on August 11, 2025, is part of Haleon’s strategic efforts to optimize its capital structure and enhance shareholder value. The buyback may influence the company’s market positioning by potentially increasing the value of remaining shares and demonstrating confidence in its financial health.
On August 11, 2025, Haleon PLC announced the purchase and cancellation of 856,760 ordinary shares as part of the second tranche of its share buyback program initiated on July 31, 2025. This transaction, which took place on August 8, 2025, reflects Haleon’s strategic focus on enhancing shareholder value and optimizing its capital structure, potentially strengthening its market position and impacting stakeholders by adjusting the number of shares with voting rights to 8,975,855,583.
On August 8, 2025, Haleon PLC announced the purchase and cancellation of 1,330,960 ordinary shares as part of the second tranche of its share buyback program initiated on July 31, 2025. This transaction, executed on August 7, 2025, is part of Haleon’s strategy to optimize its capital structure and potentially enhance shareholder value. Following this transaction, the company’s registered share capital consists of 8,980,592,548 ordinary shares, with 8,976,712,343 shares having voting rights. This move may impact stakeholders by altering the shareholding structure and potentially affecting market perceptions of the company’s financial health.
Haleon PLC, a UK-based company, reported a change in major holdings on July 11, 2025, following an acquisition or disposal of voting rights by Wellington Management Group LLP. The notification indicated that Wellington Management Group LLP’s total voting rights in Haleon PLC decreased from 5.87% to 5.29%, with the threshold being crossed on July 10, 2025. This change in holdings could potentially impact Haleon’s shareholder structure and influence in the market.
On June 27, 2025, Haleon PLC announced the completion of its acquisition of the remaining 12% equity interest in Tianjin TSKF Pharmaceutical Co. Ltd, making it a wholly owned subsidiary. This strategic move, initially announced on April 15, 2025, for RMB 1,623 million, strengthens Haleon’s position in the Chinese market, which is crucial for its growth due to favorable structural drivers. The acquisition enhances Haleon’s operational flexibility and aligns with its capital allocation priorities, promising attractive returns for shareholders and maintaining a strong investment-grade balance sheet.
On June 26, 2025, Haleon PLC announced the completion of the first tranche of its share buyback program, initially announced on March 28, 2025. The company repurchased 51,036,522 shares for approximately £200 million, all of which were canceled. This move is part of Haleon’s strategy to optimize its capital structure and potentially enhance shareholder value. The completion of this tranche may impact the company’s market positioning by reducing the number of shares with voting rights, which now stands at 8,984,453,348.
On June 25, 2025, Haleon PLC announced the purchase and cancellation of 1,009,135 ordinary shares as part of its share buyback program initiated on March 28, 2025. This transaction, completed on June 24, 2025, reflects Haleon’s strategic financial management to optimize shareholder value. The company’s registered share capital now stands at 8,989,539,664 ordinary shares, with 8,985,459,459 shares carrying voting rights. This move is expected to impact shareholder interests and aligns with regulatory requirements under the UK’s Market Abuse Regulation.